ESC Premium Access

The ORION Program - Rationale and emerging evidence

Topic: Trial Design
Sponsored by the Medicines Company

Congress Session

About the speaker

Doctor David Kallend

The Medicines Company, Zurich (Switzerland)
1 presentation
0 follower

5 more presentations in this session

Welcome and introductions.

Speaker: Doctor B. Berkowitz (New York, US)

Thumbnail

Atherosclerotic cardiovascular disease management has made significant progress but may have stalled recently.

Speaker: Doctor C. Gibson (Boston, US)

Thumbnail

LDL-C and outcomes: Implementing 21st century cardiovascular trials

Speaker: Professor L. Bowman (Oxford, GB)

Thumbnail

Another PCSK-9 therapy?

Speaker: Professor R. Wright (Rochester, US)

Thumbnail

Approaches to critically assess the evidence. A checklist for ORION-11

Speaker: Doctor C. Gibson (Boston, US)

Thumbnail

Access the full session

The ORION Program - What to look for in ORION-11

Speakers: Doctor D. Kallend, Doctor B. Berkowitz, Doctor C. Gibson, Professor L. Bowman, Professor R. Wright...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk